MTOR and tuberous sclerosis: Current pharmacological treatments include Rapalogs; these drugs that dampen mTOR activity have been used to treat TSC with some success (French et al., 2016; Bissler et al., 2017; Franz et al., 2018; Wataya-Kaneda et al., 2018).